Therapeutic Effect of Dopamine Agonist ( Dopamine ) in Comparison with Oral Contraceptives in Reducing the Size of Ovarian Benign Tumors
Phase 3
Recruiting
- Conditions
- Benign Ovarian Tumors.D27:Benign neoplasm of ovary
- Registration Number
- IRCT20180815040802N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
All women with Benign Ovarian Tumors in Reproductive Age
Exclusion Criteria
Hyperprolactinemia
Hypercoagulability State
Valvular Heart Disease
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Size of benign ovarian tumor. Timepoint: measuring the size of tumor before intervention and after the 3 months; receiving drug. Method of measurement: Trans Vaginal Ultrasound.
- Secondary Outcome Measures
Name Time Method